体外肺モデル市場：タイプ別、用途別-2023-2030年の世界予測

体外肺モデル市場は、予測期間中に16.87%のCAGRで、2022年の5億828万米ドルから2030年には17億7,017万米ドルに達すると予測されます。

体外肺モデルの世界市場

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは体外肺モデル市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.体外肺モデル市場の市場規模および予測は？

2.体外肺モデル市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.体外肺モデル市場における競争戦略の窓とは？

4.体外肺モデル市場の最新技術動向と規制の枠組みは？

5.体外肺モデル市場における主要ベンダーの市場シェアは？

6.体外肺モデル市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 動物実験に代わる倫理的な手段に対する需要の高まり
    • 創薬と開発の増加
    • 疾患調査におけるインビロ肺モデルの広範な使用
  • 抑制要因
    • 体外肺モデルの開発と維持に高額なコストがかかる
  • 機会
    • 個別化医療アプローチへの傾向
    • さまざまな物質の毒性試験に活用
  • 課題
    • in vitro肺モデルに関連する生理学的複雑性
• 市場セグメンテーション分析
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 体外肺モデル市場：タイプ別

• 2Dモデル
• 3Dモデル

第7章 体外肺モデル市場：用途別

• 3Dモデル開発
• 創薬と毒物学
• 生理学的調査
• 幹細胞調査と再生医療

第8章 南北アメリカの体外肺モデル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の体外肺モデル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの体外肺モデル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第12章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • AlveoliX AG
  • Brainlab AG
  • Cn Bio Innovations Limited
  • Emulate, Inc.
  • Epithelix Sarl
  • Hologic, Inc.
  • Horizon Discovery Group plc
  • Insphero AG
  • Lonza Group AG
  • Mattek Corporation by Bico Group
  • McKesson Corporation
  • Merck KGaA
  • MICA Information Systems, Inc.
  • Mimetas B.V.
  • PromoCell GmbH
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc
  • Tissuse GmbH
  • Varian Medical Systems, Inc
• 主要な製品ポートフォリオ

第13章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. IN VITRO LUNG MODEL MARKET RESEARCH PROCESS
• FIGURE 2. IN VITRO LUNG MODEL MARKET SIZE, 2022 VS 2030
• FIGURE 3. IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. IN VITRO LUNG MODEL MARKET DYNAMICS
• FIGURE 7. IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 8. IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 10. IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 12. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 14. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 20. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. IN VITRO LUNG MODEL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 6. IN VITRO LUNG MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. IN VITRO LUNG MODEL MARKET SIZE, BY 3D MODELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. IN VITRO LUNG MODEL MARKET SIZE, BY 3D MODEL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. IN VITRO LUNG MODEL MARKET SIZE, BY PHYSIOLOGICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL RESEARCH & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. POLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 100. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 101. IN VITRO LUNG MODEL MARKET LICENSE & PRICING

The In Vitro Lung Model Market is projected to reach USD 1,770.17 million by 2030 from USD 508.28 million in 2022, at a CAGR of 16.87% during the forecast period.

Global In Vitro Lung Model Market

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the In Vitro Lung Model Market.

Based on Type, market is studied across 2D Models and 3D Models. The 2D Models is projected to witness significant market share during forecast period.

Based on Application, market is studied across 3D Model Development, Drug Discovery & Toxicology, Physiological Research, and Stem Cell Research & Regenerative Medicine. The 3D Model Development is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the In Vitro Lung Model Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape In Vitro Lung Model Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the In Vitro Lung Model Market, highlighting leading vendors and their innovative profiles. These include AlveoliX AG, Brainlab AG, Cn Bio Innovations Limited, Emulate, Inc., Epithelix Sarl, Hologic, Inc., Horizon Discovery Group plc, Insphero AG, Lonza Group AG, Mattek Corporation by Bico Group, McKesson Corporation, Merck KGaA, MICA Information Systems, Inc., Mimetas B.V., PromoCell GmbH, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc, Tissuse GmbH, and Varian Medical Systems, Inc.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the In Vitro Lung Model Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the In Vitro Lung Model Market?

3. What is the competitive strategic window for identifying opportunities in the In Vitro Lung Model Market?

4. What are the latest technology trends and regulatory frameworks in the In Vitro Lung Model Market?

5. What is the market share of the leading vendors in the In Vitro Lung Model Market?

6. Which modes and strategic moves are suitable for entering the In Vitro Lung Model Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. In Vitro Lung Model Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for ethical alternatives to animal testing
    • 5.1.1.2. Increase in drug discovery and development
    • 5.1.1.3. Extensive use of in-viro lung model in disease research
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development and maintainence of in-vitro lung model
  • 5.1.3. Opportunities
    • 5.1.3.1. Inclination toward personalized medicine approach
    • 5.1.3.2. Utilization for toxicity testing of various substances
  • 5.1.4. Challenges
    • 5.1.4.1. Physiological complexity associated with in-vitro lung model
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. In Vitro Lung Model Market, by Type

• 6.1. Introduction
• 6.2. 2D Models
• 6.3. 3D Models

7. In Vitro Lung Model Market, by Application

• 7.1. Introduction
• 7.2. 3D Model Development
• 7.3. Drug Discovery & Toxicology
• 7.4. Physiological Research
• 7.5. Stem Cell Research & Regenerative Medicine

8. Americas In Vitro Lung Model Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific In Vitro Lung Model Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa In Vitro Lung Model Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. AlveoliX AG
  • 12.1.2. Brainlab AG
  • 12.1.3. Cn Bio Innovations Limited
  • 12.1.4. Emulate, Inc.
  • 12.1.5. Epithelix Sarl
  • 12.1.6. Hologic, Inc.
  • 12.1.7. Horizon Discovery Group plc
  • 12.1.8. Insphero AG
  • 12.1.9. Lonza Group AG
  • 12.1.10. Mattek Corporation by Bico Group
  • 12.1.11. McKesson Corporation
  • 12.1.12. Merck KGaA
  • 12.1.13. MICA Information Systems, Inc.
  • 12.1.14. Mimetas B.V.
  • 12.1.15. PromoCell GmbH
  • 12.1.16. STEMCELL Technologies Inc.
  • 12.1.17. Thermo Fisher Scientific Inc
  • 12.1.18. Tissuse GmbH
  • 12.1.19. Varian Medical Systems, Inc
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing